News

Delivra Health Brands

Delivra Health shares Q1 results of Dream Water and LivRelief brands

02/12/2022
Read more
Hygrovest News

Results of 2022 Annual General Meeting

24/11/2022
Read more
Hygrovest News

Hygrovest raises net present value by 38%; NPV per share up 30%

08/11/2022
Read more
Hygrovest News

Hygrovest Investment Portfolio Report – October 2022

08/11/2022
Read more
ValoTx

Nordic Life Sciences Interview: Valo Therapeutics CEO Paul Higham

24/10/2022
Read more
MMJ News

Presentation for HGV webinar – 21 October 2022

21/10/2022
Read more
MMJ News

HGV Investor Update – Live Audio Webinar

13/10/2022
Read more
Hygrovest News

Hygrovest Investment Portfolio Report – September 2022

10/10/2022
Read more
Hygrovest News

2022 AGM Notice of Meeting

10/10/2022
Read more
Hygrovest News

Hygrovest Annual Report – 30 June 2022

10/10/2022
Read more
Hygrovest News

 HGV Appendix 4G and Corporate Governance Statement – September 2022

21/09/2022
Read more
Hygrovest News

HGV extends the term of Parallax Ventures as Asset Manager 

20/09/2022
Read more
Hygrovest News

Hygrovest Investment Portfolio Report – August 2022

14/09/2022
Read more
Hygrovest News

Notice of change of interests of substantial holder

07/09/2022
Read more
Hygrovest News

Hygrovest Limited Appendix 4E Preliminary Final Report   

31/08/2022
Read more
Hygrovest News

Hygrovest Investment Portfolio Report – July 2022

11/08/2022
Read more
ValoTx

Valo Immuno-Oncology Treatment

09/08/2022
Read more
ValoTx

Valo Therapeutics Oy Shareholder Update 

05/08/2022
Read more
ValoTx

Valo Introduction Video

04/08/2022
Read more
Hygrovest News

Presentation for HGV webinar – 22 July 2022

22/07/2022
Read more
Hygrovest News

HGV Investor Update – Live Audio Webinar

15/07/2022
Read more
Hygrovest News

Hygrovest Investment Portfolio Report – June 2022

11/07/2022
Read more
Weed Me

Weed Me seeing strong demand for its pre rolls across Canada

06/07/2022
Read more
Hygrovest News

Notice of initial substantial holder

05/07/2022
Read more